- Tytuł:
- Isatuximab‐carfilzomib‐dexamethasone immediately after failing of the quadruplet Daratumumab‐bortezomib‐lenalidomide‐dexamethasone (Dara‐VRD): Striking response with no washout in a newly diagnosed multiple myeloma.
- Autorzy:
- Źródło:
- Clinical Case Reports. Jan2024, Vol. 12 Issue 1, p1-5. 5p.
Czasopismo naukowe